【藥品性質提示】 根據 2019 AGS Beers Criteria，本藥品為【潛在不適當用藥 (PIM)】，不建議用於老年人。

Antisecretory, antispasmodics, treatment of acute poisoning of parasympathomimetic agents

Atropine sulfate is an anticholinergic agent that specifically antagonizes the muscarine-like activity of acetylcholine and other choline esters.

Prostatic enlargement, paralytic ileus, pyloric stenosis, glaucoma, tachycardia.

C

Data controversial, but it can decrease the production of breast milk.

Tachycardia, increasing ocular tension, pupils dilatation, dry mouth, blurred vision, dysurea, headache, weakness, nausea, vomiting, restlessness, and rash.

Anticholinergic: 0.4-0.6mg IV, SC. Preanesthetic medication: 0.3-0.6mg, SC, IM or IV. Antidote of cholinesterase inhibitor: 2-4mg IV then 2mg, every 5-10min, IM, until muscarinic symptoms disappear or atropine toxicity appear.

Atropine is incompatible with alkaline solution; decomposition reported.